Rhabdomyolysis due to multifactorial causes in water intoxication patient;Rabdomiolisis de origen multifactorial en paciente con intoxicación acuosa

Revista de Toxicologia

Volumn 23, Issue 2-3, 2006, Pages 154-155

  Gutierrez Cia I ^a   Obon B ^a   Villanueva, B ^a   Montoiro, R ^a   Moragrega, B ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL OBISPO POLANCO   (Spain)

Author keywords

Atypical antipsychotic drugs; Olanzapine; Rhabdomyolysis

Indexed keywords

OLANZAPINE;

ACUTE KIDNEY FAILURE; ARTICLE; HUMAN; MUSCLE INJURY; RHABDOMYOLYSIS; WATER INTOXICATION;

EID: 33847046756     PISSN: 02127113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fernández Fúnez, A. (1998) La insuficiencia renal aguda en la rabdomiolisis. Rev Clin Esp 198(11): 758-64.
2. Franzen D, Burkhard J, Corti N, Schupbach D, Fontanel D, Staubli M. (2006) Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units. Anasthesiol Intensivmed Notfallmed Schmerzther 41(2):125-7.
3. Meltzer HY, Cola PA, Parsa M. (1996) Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacol 15(4):395-405.
4. Scneiderehan ME, Patricia AM. (1994) An atipical course of neuroleptic malignant syndrome. J Clin Pharmacol 34: 325-334
5. Hanft A, Eggleston CF, Bourgeois JA. (2004) Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine. J Child Adolesc Psychopharmacol 14(3):481-7.
6. FDA.medwatch.com
7. Koren W, Koren E, Nascsch N, Ehrenfeld M, Gur H. (1998). Rhabdomyolisis associated with clozapina treatement in a patient with decreased calcium-dependant potassium permeability of cell membranas. Clin Neuropharmacol 21(4): 262-4.
8. Renwick AC, Renwick AG, Flanagan RJ, Ferrer RE. (2000). Monitoring of clozapine and norclozapine plasma concentration-time curves in acute overdose. J. Toxicol. Clin. Toxicol 38(3): 325-8
9. Spigset O, Hedenmalm K. (1995) Hyponatraemia and ths syndrome of inappropiate antidiuretic hormone secretion (SIADH) induced by psycotropic drugs. Drug Saf. 12(3): 209-25.
10. Yamaguchi K, Hama H, Adachi C. (1990). Inhibitory role of periventricular dopaminergic mechanisms in hemorrhage induced vasopressin secretion in conscious rats. Brain Res 513(2):335-8
11. Holzbauer M, Racke K. (1985). The dopaminergic innervation of the intermediate lobe and of the neural lobe of the pituitary gland. Med Biol.63(3):97-116.
12. Wells T, Forsling ML. 1992. Aminergic control of vasopressin secretion in the conscious rat. J Physiol Pharmacol 43(1):59-64.
13. Yamaguchi K, Hama H. (1989). Facilitatory role of central dopamine in the osmotic release of vasopressin. Brain Res 481(2):388-91.
14. Littrell KH, Johnson CG, Littrell SH, Peabody CD. (1997). Effects of olanzapine on polydipsia and intermittent hyponatremia. J Clin Psychiatry 58(12):549
15. Munn NA. (1993). Resolution of polydipsia and hyponatremia in schizophrenic patients after clozapine treatment. J Clin Psychiatry 54(11):439
16. Tenyi T. Voros V. (2006). Successful switch to olanzapine after rhabdomyolysis caused by water intoxication and clozapine use. [Case Reports. Letter] Pharmacopsychiatry. 39(4):157-8.
17. Rizzeri, DA. (1995). Rhabdomyolysis after correction of hyponatremia due to psycogenetic polydipsia. Mayo Clin Proc. 70: 473-476
18. Wicki J, Rutschmann OT, Burri H, Vecchietti G, Desmeules J. (1998) Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia possibly complicated by clozapine. Ann Pharmacother. 32(9):892-5.